Phosphorylation of intestine-specific homeobox by ERK1 modulates oncogenic activity and sorafenib resistance

Li-Ting Wang1, Kwei-Yan Liu2, Shyh-Shin Chiou3

  • 1Department of Life Science, National Taiwan Normal University, Taipei, Taiwan.

Cancer Letters
|July 15, 2021
PubMed

Insights

Extracellular signal-regulated kinase 1 (ERK1) phosphorylates intestine-specific homeobox (ISX), promoting its nuclear entry and driving hepatocellular carcinoma (HCC) progression. This ERK1/ISX pathway is a potential therapeutic target for HCC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Mitogen-activated protein kinases (MAPKs) regulate nuclear translocation for target gene access, but their role in oncogenesis is not fully understood.
  • Mechanisms linking MAPK signaling to cancer-driving gene expression require elucidation.

Purpose of the Study:

  • To investigate the role of extracellular signal-regulated kinase 1 (ERK1) and intestine-specific homeobox (ISX) in hepatocellular carcinoma (HCC) progression.
  • To identify the specific phosphorylation site and downstream effects of ERK1 on ISX.

Main Methods:

  • Phosphorylation assays to identify the target site of ERK1 on ISX.
  • In vitro and in vivo experiments using hepatoma cells with dominant-negative ERK1 or mutated ISX.
  • Analysis of ERK1 and ISX expression in clinical HCC samples.

Main Results:

  • ERK1 specifically phosphorylates serine 183 of ISX, promoting its nuclear translocation and oncogenic signaling.
  • Inhibition of ERK1 reduces ISX nuclear translocation and downstream gene expression linked to proliferation, transformation, and epithelial-mesenchymal transition.
  • Mutated ISX (S183D) shows constitutive nuclear localization and sorafenib resistance.
  • ERK1 and ISX are co-expressed in HCC tissues and correlate with tumor progression and patient survival.

Conclusions:

  • The ERK1-mediated phosphorylation of ISX is a critical driver of HCC progression.
  • The ERK1/ISX signaling pathway represents a potential prognostic biomarker and therapeutic target for HCC.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.3K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.2K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.7K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.2K